Australian Medicines Shortages Bill Outlines 'Critical Impact' Criteria
Legislation that would introduce the proposed mandatory scheme for reporting medicines shortages has come before the Australian parliament. Among other things it specifies which shortages would have a "critical impact" on patient health.
You may also be interested in...
Drug sponsors will face penalties in Australia if they fail to comply with new rules on the mandatory reporting of medicines shortages that come into effect at the beginning of 2019 to replace the current "ineffective" voluntary system.
As it presses on with plans to make the reporting of medicines shortages mandatory in Australia, the Therapeutics Goods Administration has taken on board industry’s concerns over how the new scheme will work.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.